Skip to main content

Akebia Therapeutics, Inc 10-Q for FY2026 Q2

Akebia Therapeutics, Inc. (AKBA)

10-Q 2026-08-05 For: 2026-06-30
View Original
Added on August 05, 2026

About this 10-Q

Akebia Therapeutics, Inc filed this 10-Q on August 5, 2026, covering the quarter ended June 30, 2026 (FY2026 Q2).

Headline figures

Quarter ended June 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$49.13M
down 21.4% from $62.47M a year earlier
Net loss
$8.91M
compared with net income of $247K a year earlier
Diluted EPS
-$0.03
compared with $0.00 a year earlier